The yeast CDC9 gene encodes a DNA ligase I activity required during nuclear DNA replication to ligate the Okazaki fragments formed when the lagging DNA strand is synthesised. The only other DNA ligase predicted from the yeast genome sequence, DNL4/LIG4, is specifically involved in a non-homologous DNA end-joining reaction. What then is the source of the DNA ligase activity required for replication of the yeast mitochondrial genome?
Background
DNA ligases have important roles in several aspects of DNA metabolism including replication, recombination and repair. In mammalian nuclear extracts, four different classes of ligase have been identified. DNA ligase I functions in the ligation of Okazaki fragments, which are formed when the lagging strand of DNA is synthesised during replication [1, 2] , and has been further implicated in DNA repair [3] . DNA ligase III interacts with the XRCC1 protein, which is known to be involved in both recombination and repair, thus implicating DNA ligase III in these processes [4, 5] . A testis-specific splice variant of DNA ligase III has also been identified, which does not interact with XRCC1 and whose specific role is currently unknown [6] . DNA ligase II is smaller than DNA ligase III but the degree of structural similarity between the two has led to the suggestion that DNA ligase II might correspond to either a splice variant or a proteolytic derivative of DNA ligase III [7, 8] . Finally, DNA ligase IV has a different substrate specificity from DNA ligases I and III and is essential in mice, but its biological role has not yet been defined [9, 10] . In Saccharomyces cerevisiae, the CDC9 gene encodes a DNA ligase I that is essential for completion of DNA synthesis [11] . Conditional lethal cdc9 mutant cells are defective in ligation of Okazaki fragments, are hypersensitive to DNA-damaging agents, and show enhanced frequency of mitotic recombination. Consistent with its role in DNA replication, the expression of CDC9 has been shown to be cell cycle regulated in exponentially growing cells with its transcript level reaching a maximum at the G1-S boundary [12, 13] . Nevertheless, expression of CDC9 can also be induced in stationary-phase cells upon exposure to DNA-damaging agents, thereby satisfying the requirement for Cdc9p in DNA repair [11, 14] .
A second DNA ligase with DNA end-joining activity has been identified in yeast cell extracts [15] and seems likely to correspond to the product of an open reading frame (ORF) designated YOR005c, identified in the yeast genome as a homologue of mammalian DNA ligase IV. In three independent studies using reverse genetic analysis [16] [17] [18] , it has been demonstrated that YOR005c does indeed encode a ligase activity; the ORF has been renamed DNL4 [18] and LIG4 [16, 17] . The DNL4/LIG4 gene predicts a 109 kDa polypeptide product that shares 25% sequence identity with mammalian DNA ligase IV but only 21% identity with yeast Cdc9p. Unlike CDC9, the DNL4/LIG4 gene is not essential for growth; indeed null mutant cells exhibit no obvious defects in either DNA replication or excision-repair [16] [17] [18] . Nevertheless, dnl4/lig4 mutant cells have been shown to sustain a substantially reduced level of non-homologous DNA endjoining, suggesting a role for Dnl4p/Lig4p in this process in vivo [16, 18] .
Given its role in nuclear DNA replication, it is not surprising that the mammalian DNA ligase I has been shown to be located in the nucleus [19] . The absence of any further ligase homologues in the yeast genome, however, raises an important question as to the source of DNA-ligase activity that would be required for the replication of the mitochondrial genome. The yeast mitochondrial genome is an 85.78 kb covalently closed circle encoding a small number of mitochondrial proteins, none of which show any similarity to known ligases. As CDC9 encodes the only replication-specific ligase currently known in yeast, we undertook a detailed analysis of the expression and intracellular localisation of the CDC9 gene product. We report that CDC9 encodes two distinct polypeptide products that are translated from separate in-frame initiation codons. The longer form is targeted to the mitochondrion where it is required for mitochondrial DNA replication. The shorter polypeptide product is targeted to the nucleus and is essential for nuclear DNA replication and cell viability.
Results

Expression and localisation of Cdc9-GFP fusion proteins
Previous studies have shown that transcription of CDC9 initiates 39-41 bp upstream of the first AUG codon (AUG 1 ) in the ORF [11, 14] . Translation initiation at AUG 1 would yield a 755 amino-acid polypeptide with a predicted molecular weight of 84.8 kDa [11] . Analysis of the CDC9 sequence, however, revealed several further in-frame methionine codons including AUG 2 , AUG 3 and AUG 4 located at codons +24, +48 and +66, respectively ( Figure 1a) . To determine which, if any, of these four potential start codons might initiate translation of Cdc9p in vivo, a series of GFP fusion proteins were generated and the products detected by western blotting with anti-GFP antibodies ( Figure 2 ). Cells transformed with a vector expressing GFP alone (pUG23) contained a single immunoreactive band of the expected relative molecular weight of 26.8 kDa. Cells carrying a plasmid in which GFP was fused after AUG 3 (pMW182) contained three immunoreactive species of 34.1, 31.5 and 29.0 kDa, consistent with initiation at AUG 1 , AUG 2 and AUG 3, respectively (Figure 2b) . Similarly, three distinct species were observed when GFP was fused after codon 70 downstream of AUG 4 (in plasmid pMW181). The relative molecular weights of these three species (35.4, 32.8, 30 .3 kDa) were again consistent with initiation at each of the first three AUG codons. No species was detected with the mobility expected from initiation at the fourth AUG.
We noted that residues 1-23 of Cdc9p could form an amphipathic α helix with properties similar to those commonly found in mitochondrial pre-sequences (see Figure 1b ) [20] . Should this constitute a functional presequence, then full-length Cdc9p might be predicted to be targeted to the mitochondrial matrix where the presequence might be removed by mitochondrial presequence peptidase (MPP) [21] . Indeed, a consensus cleavage site for MPP cleavage exists in the sequence ARFFT (in the single-letter amino-acid code; amino-acid residues 42-46), predicting cleavage between residues F44 and F45 (Figure 1a ; [22] ). Such a cleavage product would be very similar in molecular weight to any bona fide translation product initiated from the nearby AUG 3 . To distinguish these possibilities, we mutated both the AUG 2 and AUG 3 codons in the AUG [1] [2] [3] [4] construct to GCG (Ala) and then examined the expression profile in vivo (AUG 1,4 -GFP; Figure 2b ). Cells carrying this construct (pMW197) were found to express two major bands with gel mobilities indistinguishable from the 35.4 and 30.3 kDa forms observed with the wild-type AUG 1-4 -GFP construct; the 32.8 kDa form predicted to initiate at AUG 2 was lacking, however ( Figure 2b; lanes 3,4) . The presence of the 30.3 kDa form in pMW197-containing cells
Figure 1
Structure of the CDC9 ORF. (a) Predicted protein sequence. Asterisks, the four aminoterminal methionine codons (AUG 1-4 ); arrow, consensus site for possible cleavage by the MPP [22] (the location of the cleavage site between residues 44 and 45 suggests that the first 44 amino-terminal residues (boxed) might represent a mitochondrial pre-sequence); underlined sequences, nuclear localisation signals [22] ; inverted black triangle, position of the triple HA epitope tag inserted in strain MDY26 (see Materials and methods). (b) Alpha-helical wheel of the first 18 residues (shown in single-letter amino acid code) of the predicted Cdc9 protein reveals an amphipathic structure characteristic of mitochondrial targeting sequences [20] .
Black circles, hydrophobic residues; +, positively charged residues. indicates that it cannot be a product of initiation at AUG 3 , but rather suggests that it must be a proteolytic product of the full-length polypeptide expressed from AUG 1 . If this processing was by MPP, then the 30.3 kDa form would be expected to fractionate with mitochondria. Therefore, purified mitochondria and a cytosolic fraction were prepared from cells carrying the AUG 1-3 -GFP fusion construct (pMW182) and analysed by western blotting (Figure 2c ). The 34.1 and 29.0 kDa forms were found to cofractionate with purified mitochondria, whereas the 31.5 kDa form was exclusively located in the cytosolic fraction. The small proportion of 29.0 kDa species present in the cytosol might have been released from broken mitochondria or might reflect very limited translational initiation from AUG 3 .
To confirm that cofractionation of Cdc9-GFP with purified mitochondria reflects authentic localisation to this compartment, we next examined the patterns of GFP fluorescence in intact cells. Cells carrying pMW181 (AUG 1-4 -GFP) were first compared, using conventional fluorescence microscopy, with those expressing GFP alone (pUG23). Cells carrying the GFP vector exhibited a strong generalised background staining consistent with a predominantly cytoplasmic localisation. In contrast, cells expressing Cdc9-GFP exhibited a strong pattern of green fluorescence localised to tubular and punctate structures, with a weak general background fluorescence (see Supplementary material published with this article on the internet). Control cells lacking GFP exhibited no fluorescence signal (data not shown). There was considerable correspondence between the tubular/punctate staining observed with Cdc9-GFP and extranuclear 4,6-diamidino-2-phenylindole (DAPI) staining of mitochondrial DNA, consistent with a mitochondrial localisation for Cdc9-GFP (see Supplementary material). This was confirmed by colocalisation of Cdc9-GFP with the mitochondrial heat-shock protein Hsp60, observed by confocal immunofluorescence microscopy ( Figure 3a,b) . The Hsp60 staining was strikingly similar to the pattern of Cdc9-GFP fluorescence observed in these cells (Figure 3a) . Indeed, a merged image of Hsp60 and Cdc9-GFP staining in a dividing cell showed precise colocalisation of the two signals ( Figure 3b ). These data clearly indicate that the amino-terminal region of Cdc9p does indeed contain a functional mitochondrial pre-sequence. Moreover, the data indicate that both AUG 1 and AUG 2 in yeast CDC9 can initiate translation of a GFP fusion protein in vivo, and suggest that the longer translation product is targeted to the mitochondrion where it is processed by MPP.
Epitope tagging of full-length Cdc9
To detect the yeast CDC9 gene product, we first introduced a triple HA tag using the transposon insertion/excision method developed by Ross-MacDonald et al. ([23] ; Cdc9-HA). Several insertions were obtained that did not interfere with the normal growth rates of haploid strains, indicating that these tagged alleles retained full Cdc9 activity. Western blot analysis revealed that, in all cases, these cells contained a doublet of immunoreactive bands with relative gel mobilities of approximately 90-93 kDa. This is marginally smaller than the 94.9 kDa predicted from the sequence of the epitope-tagged Cdc9-HA. The results for one such insertion are shown in Figure 4a ; this particular strain (MDY26) was used in the remaining experiments.
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Figure 2
Cdc9-GFP constructs are translated from multiple start codons and proteolytically processed in mitochondria. (a) The 5′ end of the CDC9 ORF is shown schematically with the positions of AUG 1-4 indicated to scale. The structure of potential GFP fusion proteins expressed from AUG 1-3 in pMW182 and AUG [1] [2] [3] [4] in pMW181 are shown, together with their predicted molecular weights. M, initiating methionine residue; grey box, GFP; arrow, putative site of mitochondrial pre-sequence processing. The AUG 2 and AUG 3 codons in pMW182 were both mutated to GCG to produce pMW197 (AUG 1,4 ) as described in the Materials and methods section. Next, we determined the localisation of the functional Cdc9-HA protein by sub-cellular fractionation. Mitochondria were purified by differential centrifugation as described [24] . The mitochondrial fraction was shown to be devoid of nuclear contamination by western blotting with antibodies against several nuclear proteins including Npl3 (Figure 4b ), Swi3 and histone H3 (data not shown).
As expected, the mitochondrial fraction was found to be enriched for a variety of mitochondrial proteins examined, namely Hsp60 (Figure 4b ), Mdh1 and Porin (data not shown). Western blotting with anti-HA antibodies revealed that the mitochondrial fraction contained significant levels of Cdc9-HA ( Figure 4b ).
Enriched nuclear preparations were resolved by sucrose step-gradient centrifugation. As previously reported [25] , we found that intact nuclei, observed microscopically, were present at the interface between 1.5-1.8 M sucrose, corresponding to a peak of Npl3 protein detected by western blotting (Figure 4b, lanes 9-11) . A substantial amount of Npl3 was also detected at the top of the gradient ( Figure 4b, lanes 2-3) . This might reflect a cytosolic pool of Npl3, but might be largely due to a combination of nuclear breakage and the leakage of proteins through nuclear pores during the fractionation procedure. The distribution of other nuclear markers tested, Swi3 and histone H3, were identical to that of Npl3 (data not shown). As expected, there was a distinct peak of Cdc9-HA that precisely coincided with the peak of intact nuclei (Figure 4b , lanes 9-11), indicating that a proportion of Cdc9-HA is localised to the nucleus. The fractions containing intact nuclei showed marginal contamination with mitochondrial Hsp60, which was predominantly located towards the top of this gradient ( Figure 4b, lanes 2-3) . Identical staining profiles were also seen with other mitochondrial markers Mdh1 and Porin (data not shown).
The nuclear and mitochondrial forms of Cdc9-HA exhibit different properties
Copurification of Cdc9-HA with mitochondria is consistent with the localisation observed for Cdc9-GFP. To confirm that Cdc9-HA is imported into mitochondria, as opposed to being associated with the outer surface of the organelle, we performed protease-protection studies. Purified nuclei and mitochondria were separately incubated with proteinase K in the presence or absence of the detergent Triton X-100. Following incubation, extracts were analysed by western blotting with anti-HA antibody to detect any undigested Cdc9-HA protein. The mitochondrion-associated form of Cdc9-HA was found to be protected from proteolysis in the absence of detergent but was completely sensitive to proteinase K digestion when incubations were performed in the presence of detergent (Figure 5a ). Identical results were obtained for the mitochondrial matrix protein Hsp60 (Figure 5b ). As a control, the purified mitochondria were shown to be devoid of contamination with a nuclear marker (Figure 5c ). These results indicate that the mitochondrion-associated form of Cdc9-HA is entirely sequestered within a membranebound compartment.
The protease accessibility of nucleus-associated Cdc9-HA was found to be very different. In this case, Cdc9-HA remained stable during mock incubations in the absence of protease, but was digested upon incubation with protease either in the presence or absence of detergent ( Figure 5d ). Identical results were obtained for Npl3 (Figure 5f ), consistent with free diffusion of small proteins such as proteinase K into the nuclear compartment through nuclear pores. As discussed previously, we found minor contamination of the nuclear fraction with mitochondrial Hsp60 and, once again, we found that this was protected from proteolysis in the absence of detergent ( Figure 5e ). These results indicate that the nucleusassociated and mitochondrion-associated forms of Cdc9-HA are topologically distinct. Moreover, we have noted that the two forms of Cdc9-HA exhibit different gel mobilities. The nuclear form migrated more slowly in SDS-PAGE than did the mitochondrial form and these two distinct species corresponded closely to the bands of the Cdc9-HA doublet observed in the total cell extract ( Figure 6 ). Taken together, these data indicate the presence of two distinct forms of Cdc9-HA expressed in MDY26 cells. The larger form is localised in the nuclear compartment, whereas the smaller form is localised in mitochondria. The difference observed in relative molecular weights would be consistent with the nuclear form being the primary translation product initiated from AUG 2 , the mitochondrial form being initiated at AUG 1 , and the pre-sequence processed as predicted between residues 44 and 45.
AUG 1 of CDC9 is required for the maintenance of the mitochondrial genome
Yeast cells require mitochondria for growth, but the mitochondrial genome itself is dispensable. Nevertheless, mutants lacking some or all of the mitochondrial genome lack enzymes required for respiratory growth. Such mutants ('petite' mutants) are therefore unable to grow on non-fermentable carbon sources such as glycerol. If the mitochondrial and nuclear forms of Cdc9 are expressed from AUG 1 and AUG 2 , respectively, then a mutation in AUG 1 might be predicted to disrupt the replication of the mitochondrial genome without impacting on the essential nuclear function of DNA ligase. To test this hypothesis, both AUG 1 and AUG 2 were individually mutated and the effects on functional expression of CDC9-HA determined. AUG 1 was mutated to a UAG stop codon, and AUG 2 to GCG (Ala). The individual mutations were integrated into a diploid strain, and the heterozygous diploids dissected and grown on glucose. In either case, viable haploids were recovered carrying the mutant cdc9 allele. A haploid strain carrying the AUG 1 →UAG mutation grew well on glucose medium but was unable to grow on glycerol, demonstrating that these cells were petite ( Figure 7 ). This compares with otherwise isogenic wild-type and AUG 2 →GCG strains, which grew normally on glycerol ( Figure 7) .
Western blot analysis clearly demonstrated that the upper form of the Cdc9p doublet was absent in AUG 2 →GCG mutant cells, whereas the lower form of the doublet was lacking in the AUG 1 →UAG mutant, thus confirming that these forms are indeed expressed from different AUG codons (data not shown). As CDC9 is an essential gene, we were initially surprised by the finding that AUG 2 →GCG cells were viable. This anomaly would be most easily explained if, in the absence of AUG 2 , a scanning ribosome were to now initiate at AUG 3 to yield a functional nuclear form of Cdc9p. Western blot analysis of the AUG 2 →GCG mutant strain suggested that this was indeed the case (data not shown). From these data, we conclude that the mitochondrial form of Cdc9p is required for the stable maintenance of mitochondrial DNA but not for cell division.
Research 20) were subjected to western blotting with antibodies specific to Npl3, HA, or Hsp60. Mitochondria (mito) were purified from the same cells (see the Materials and methods section) and equivalent amounts of these were then analysed by western blotting using the same three antibodies.
Discussion
Mitochondrial DNA replication ought to require an activity similar to DNA ligase I for the ligation of Okazaki fragments. Analysis of the coding sequence of the yeast CDC9 gene led us to speculate that this gene might encode both a nuclear and a mitochondrial form of DNA ligase I. The ORF has several in-frame AUG codons towards its 5′ end as originally noted by Barker et al. ([11] ; see Figure 1 ). Translation from AUG 1 would lead to a 755 amino-acid primary translation product of which the amino-terminal region has several properties characteristic of a mitochondrial pre-sequence, most notably, a putative amphipathic α-helical region (residues 1-18) with a positively charged face, a general lack of acidic residues and a preponderance of hydroxylated residues. Moreover, this putative matrixtargeting signal is followed, between residues 44 and 45, by a potential site for specific cleavage by the MPP located within the mitochondrial matrix [20, 22] .
Cleavage at this site would predict a mature mitochondrial form with a molecular weight of 80.1 kDa, compared with a predicted primary translation product of 84.8 kDa. Initiation of translation solely at the AUG 1 codon would endow every Cdc9 molecule with this putative pre-sequence. Any model for Cdc9 expression would have to account, therefore, for the required expression of a nuclear form of this enzyme. Translational initiation at AUG 2 would accommodate this as it would result in a 732 amino-acid primary translation product (82.3 kDa) lacking the amphipathic region discussed above, but which would still contain the three putative nuclear localisation signals indicated in Figure 1a . This model therefore predicts two forms of Cdc9p in wild-type yeast cells and, indeed, Tomkinson et al. [26] reported the purification of wildtype Cdc9p as a tight doublet of approximately 80 kDa with an additional 70 kDa proteolytic fragment corresponding to an enzymatically active carboxy-terminal portion of Cdc9p.
To test this model, we first engineered several CDC9-GFP gene fusions and, by western blot analysis, determined the nature of the fusion proteins expressed in vivo. When GFP was fused downstream of either AUG 3 or AUG 4 , translation products were observed in both cases with relative molecular weights very closely comparable to those expected from initiation at both AUG 1 and AUG 2 . In addition, each construct led to the expression of a third major form whose mobility would be consistent either with initiation at AUG 3 or with a mitochondrial processing product (Figure 2 ). When the products from AUG 1-4 -GFP were compared with those of a mutant derivative in which both AUG 2 and AUG 3 were replaced, then a clearer picture emerged. Firstly, the 32.8 kDa product predicted to arise from initiation at AUG 2 was now absent, whereas the smaller form remained unaffected (Figure 2b ). From this, it is clear that this smaller fusion protein cannot arise through initiation at AUG 3 . Fractionation studies of the three products expressed from AUG 1-3 -GFP revealed that the intermediate species (the size of which was consistent with initiation at AUG 2 ) remained in the soluble cytosolic phase whereas the other two forms fractionated with mitochondria.
These results would be consistent with translational initiation of Cdc9-GFP at both AUG 1 and AUG 2 . The fusion protein observed with an intermediate gel mobility would correspond to the product of initiation at AUG 2 . The largest species would correspond to the primary translation product from AUG 1 , with the smallest form being derived from this by removal of the pre-sequence on import into mitochondria. Our fractionation studies indicated that both the largest and smallest forms of Cdc9-GFP were mitochondrially associated. It is not clear why a small proportion of the fusion should remain unprocessed although it may be due to some overexpression from the multicopy plasmid constructs. The cofractionation of Cdc9-GFP with mitochondria was confirmed by confocal microscopy in intact cells where it was found that the majority of the Cdc9-GFP signal was precisely colocalised with the mitochondrial marker, Hsp60 (Figure 3 ). These results indicate that Cdc9-GFP can be expressed from each of two consecutive AUG codons corresponding to AUG 1 and AUG 2 of CDC9, and that the first of these incorporates a functional mitochondrial pre-sequence which is cleaved upon import into mitochondria.
We went on to examine the cellular distribution of an HAtagged derivative of Cdc9p. The tagged CDC9-HA gene expressed functional ligase activity as it could support wild-type growth rates in a haploid strain background. Moreover, the tagged Cdc9-HA protein migrated as a doublet in SDS-PAGE as did native Cdc9p (Figure 4a ; [26] ). Nuclei and mitochondria were purified from cells expressing Cdc9-HA, and western blotting studies revealed substantial levels of Cdc9-HA in both organelles (Figure 4b ). These two pools of Cdc9-HA were further distinguished by their protease accessibility in which it was evident that the mitochondrion-associated form was entirely sequestered within a sealed membrane-bound compartment. In contrast, the nuclear form remained characteristically accessible to protease ( Figure 5 ). Moreover, the two forms could be resolved by SDS-PAGE and their different mobilities would appear to account for the Cdc9-HA doublet observed in whole cell extracts (Figure 6 ), the higher molecular weight band of the doublet apparently corresponding to the nuclear form and the faster-migrating species being indistinguishable from the mitochondrial form. Overall, these data indicate that yeast Cdc9 is expressed in two topologically distinct isoforms from adjacent AUG codons in the CDC9 ORF.
The biological significance of these observations was confirmed by our findings of the phenotypes of AUG mutants engineered into the otherwise wild-type CDC9 gene. A mutant lacking AUG 1 remained viable but became petite ( Figure 7 ). From this, it is evident that initiation at AUG 1 is required to produce the DNA ligase necessary to maintain mitochondrial DNA, but is not required for replication of the nuclear genome. Our data further demonstrate that the nuclear form of Cdc9p is normally expressed from AUG 2 , but that initiation at this codon is not essential for viability because of the close proximity of AUG 3 , only 24 codons downstream. In the absence of AUG 2 , a functional form of Cdc9p is initiated at AUG 3 .
The expression of two distinct isoforms of DNA ligase I might not be restricted to S. cerevisiae. We have found strong candidates for amino-terminal mitochondrial presequences encoded by both the Schizosaccharomyces pombe cdc17 gene [27] and a DNA ligase I homologue from Arabidopsis thaliana [28] . In each case, the putative presequence is closely followed by a second in-frame AUG codon. Interestingly, the sequence of the cloned human DNA ligase I cDNA does not encode any recognisable mitochondrial pre-sequence. There could of course be some cryptic mitochondrial import signal, or perhaps an alternatively spliced mRNA that might incorporate a mitochondrial pre-sequence. Alternatively, a second DNA ligase I homologue in the human genome might encode a mitochondrial form of this enzyme. Intriguingly, expression of the human cDNA complements the growth defect in a yeast cdc9-1 mutant [29] . It would be very interesting to examine the respiratory competence of such cells to test for the human enzyme's ability to complement any mitochondrial defect. Interestingly, a DNA ligase III activity
Figure 7
Functional distinction between Cdc9 encoded from AUG 1 and AUG 2 . After tetrad analysis, haploid leucine auxotrophs were tested for growth on YPD (glucose) and YPEG (glycerol) media. The yeast strains were MWY21 (wild type), MWY32 and MWY51 (heterozygous diploids in which one copy of CDC9 was engineered to alter either AUG 1 or AUG 2 , respectively). The specific mutations were AUG 1 →UAG and AUG 2 →GCG. has been identified in mitochondrial extracts from Xenopus laevis [30] . More recently, it has been shown that human DNA ligase III is expressed in both nuclear and mitochondrial forms from tandem AUG codons [31] in a manner which appears similar to that described here for yeast CDC9. DNA ligase III has been implicated primarily in DNA repair and recombination but might also perform the replication role required in the human mitochondrion. Although antisense inhibition studies indicate that DNA ligase III is the major source of ligase activity in the human mitochondrion, they do not, however, exclude the possibility that other forms of DNA ligase may also function in this compartment [31] .
GCG
In eukaryotes, the majority of proteins studied have been shown to be accurately and efficiently sorted to a single cellular compartment. Nevertheless, several examples are now known where an enzyme can be expressed in two or more isoforms from a single genetic locus (for a review, see [32] ). These isoforms can carry distinct targeting signals leading to their being sorted to different compartments. A variety of mechanisms can account for the expression of distinct isoforms but, in yeast, the majority of cases rely on either altered transcriptional or translational initiation to produce isoforms which differ at their amino termini (see [32] and references therein). From our current data, we cannot determine whether the mechanism responsible for expression of distinct isoforms of Cdc9p operates at the transcriptional or the translational level. Previous studies have reported a single transcriptional initiation site upstream of the first AUG codon of CDC9 [11, 14] . It would therefore follow that some post-transcriptional mechanism must serve to ensure the expression of the nuclear form of yeast DNA ligase I. The nature of this control mechanism is currently under investigation.
Materials and methods
Strains and culture conditions
All yeast strains used in this study are derived from W303 (MATa/MATα ura3-1/ura3-1 leu2-3,112/leu2-3,112 trp1-1/trp1-1 his3-11/his3-11 ade2-1/ade2-1 can1-100/can1-100) including the haploid wild-type derivative W303-3c (MATa, ura3-1-1 leu2-3,112  trp1-1-1 his3-11 ade2-1 can1-100) , MDY26 (as W303-3c but CDC9-HA), MWY21 (as W303 but CDC9/cdc9-HA::pMW185), MWY32 (as W303 but CDC9/cdc9-HA::pMW186), and MWY51 (as W303 but CDC9/cdc9-HA::pMW190). Yeast cultures were grown in either YPD (2% peptone, 1% yeast extract, 2% glucose) or, to maintain selection in YNB (0.675% yeast nitrogen base, 2% glucose), supplemented with appropriate amino-acid supplements. Mitochondrial function was assessed by plating cells on YPEG (2% peptone, 1% yeast extract, 3% glycerol, 3% ethanol). Sporulation and tetrad dissection were performed as described previously [33] .
Generation of CDC9-GFP fusions
Expression vector pUG23 for carboxy-terminal GFP fusions was kindly provided by J.H. Hegemann. Two plasmids containing various lengths of the amino terminus of CDC9 fused in frame to GFP under the control of a MET25 promoter were constructed. CDC9 was amplified by PCR with primers A (5′-CATCTAGAACATGCGCAGATTACTG-3′) and B (5′-GGAGATCTAGTGAATTCTGTTGGCTTATTTTTC-3′) and subcloned into the EcoRV site of pBluescript KS+ (pMW178); pMW178 was subsequently digested with XbaI and EcoRI and the 172 bp CDC9 fragment was cloned into the XbaI-EcoRI sites of pUG23. The resulting plasmid (pMW182) contains GFP fused in frame after residue 54 of CDC9. A similar construct (pMW181) was made by cloning a 223 bp XbaI-BamHI fragment of the PCR product with primers A and C (5′-CTATCGATATGCATTCTATCTTCCAGCATAT-3′) into the XbaI-BamHI sites of pUG23. In this construct, GFP is fused to CDC9 after residue 70. The entire inserts of both plasmids were sequenced by automated sequencing.
Subcellular fractionation
Yeast mitochondria and a post-mitochondrial supernatant were prepared as described previously [24] . Yeast nuclei were prepared as follows. Cells were grown in YPD to mid-exponential phase, harvested by centrifugation and converted into sphaeroplasts [24] , which were pelleted, washed twice with 1.2 M sorbitol, 20 mM potassium phosphate pH 6.5 and resuspended in cold 18% Ficoll 400 (w/v), 20 mM potassium phosphate pH 6.5, 0.5 mM MgCl 2 . Sphaeroplasts were then homogenised by two strokes with a Dounce homogeniser on ice. An equal volume of 2.4 M sorbitol, 20 mM potassium phosphate pH 6.5, 0.5 mM MgCl 2 was added and the homogenate was spun at 1000 × g for 10 min at 4ºC to remove unbroken cells and cell debris. The supernatant was transferred to a fresh tube and nuclei were pelleted by centrifugation at 12000 × g for 25 min at 4ºC. The pellet was resuspended in a small volume of 1.2 M sorbitol, 20 mM potassium phosphate pH 6.5, 0.5 mM MgCl 2 and layered on top of a three-step glycerol gradient as described by Kalinich and Douglas [34] . The nuclear fraction was then further purified by centrifugation on a sucrose gradient as described by Hurt et al. [25] . Proteinase K treatment of isolated mitochondria and nuclei was carried out by adding an equal volume of 500 µg/ml proteinase K in 0.6 M mannitol, 10 mM Tris-HCl pH 7.4. Triton X-100 was added to a final concentration of 0.5%. After incubation at 0ºC for 30 min, proteins were TCA precipitated. SDS-containing sample buffer was added and the samples were immediately heated to 95ºC for 4 min and analysed by SDS-PAGE as described below.
Western blotting
Methods for the preparation of whole cell extracts and for SDS-PAGE and immunoblotting were as described previously [33] . Antiserum directed against yeast Hsp60 was used at 1:10,000 dilution (K. Tokatlidis, personal communication), anti-Npl3 antiserum at 1:3000 dilution (A.H. Corbett, personal communication), anti-GFP antiserum at 1:1000 dilution and anti-HA monoclonal antibody (12CA5/Boehringer Mannheim) at 1:1000 dilution. Secondary HRPconjugated anti-rabbit antibody (Sigma) and HRP-conjugated antimouse antibody (DAKO) were both used at a 1:10,000 dilution before detection with Renaissance ECL (NEN).
Site-directed mutagenesis of CDC9
A 1136 bp PstI-XhoII fragment from pR12ScLig2 [35] containing the promoter region and part of the CDC9 ORF was cloned into the PstI-BamHI sites of YIp351 [36] . The resulting plasmid, pMW185 was subjected to site-directed mutagenesis performed with Quickchange site-directed mutagenesis kit (Stratagene) according to the manufacturer's instructions. The first ATG of the CDC9 ORF in pMW185 was changed to TAG (stop codon) using primers D (5′-CATTGTTCATCAAT-TACTAGCGCAGATTACTGACC-3′) and E (5′-GGTCAGTAATCT-GCGCTAGTAATTGATGAACAATG-3′) to produce pMW186. In pMW190, the second ATG of the CDC9 ORF in pMW185 was changed to GCG (Ala) with primers F (5′-CCTTGAAATCAAGATTGC-CATTATTGGCGTCATCCTCATTACCTTCC-3′) and G (5′-GGAAG-GTAATGAGGATGACGCCAATAATGGCAATCTTGATTTCAAGG-3′). The inserts of pMW186 and pMW190 were sequenced to verify the changes of the DNA sequence. Subsequently, the two mutant plasmids and a wild-type control (pMW185) were linearised with NdeI and transformed into MDY26 (CDC9/CDC9-HA) selecting for leucine auxotrophy. All integrations were confirmed by PCR of genomic DNA using primers J (5′-CCGGATCTATGCGGTGTGAAATAC-3′) and K (5′-ATGCACCTGAGCCCTTTCACCATC-3′). The diploid strains containing the integrated constructs were named: MWY21 (pMW185/wild-type), MWY32 (pMW186/AUG 1 →UAG) and MWY51 (pMW190/AUG 2 →GCG). All three strains were transformed with pR12ScLig2 selecting for leucine/uracil auxotrophy and tetrad analysis revealed a 2:2 segregation of the leucine auxotrophy, suggesting a single integration event in each of the strains MWY21, MWY32 and MWY51. Finally, the effects of the individual ATG mutants were assessed by tetrad analysis of the three diploid strains. Mutagenesis of the second and third ATG in pMW181 (CDC9-GFP, described above) was performed in two steps: the third ATG of CDC9 in pMW181 was changed to GCG with primers H (5′-GGCTA-GATTCTTCACTTCCGCGAAAAATAAGCCAACAGAAGG-3′) and I (5′-CCTTCTGTTGGCTTATTTTTCGCGGAAGTGAAGAATCTAGCC-3′), resulting in pMW197 in which the second ATG was changed to GCG with primers F and G (pMW198). The correct changes were verified by DNA sequencing.
Immunofluorescence microscopy
Cells were grown to mid-logarithmic phase in minimal media selecting for the presence of plasmid, as appropriate, and fixed by addition of formaldehyde to a final concentration of 4.4% and subsequently treated as described [37] . Cells were incubated for 60 min with 1:1000 dilution of anti-Hsp60 antisera in PBS + 1 mg/ml BSA. Cy3-coupled anti-rabbit secondary antibody was used at 1:1000 dilution for 60 min. Hsp60 staining was visualised by immunofluorescence microscopy using a Leica TCS NT confocal microscope and associated software supplied by the manufacturer. Simultaneous recording of GFP signal was performed and 25 individual sections throughout each sample were integrated.
Epitope tagging with transposon
As a target for mTn3-3xHA/lacZ transposon insertion, a 1886 bp BglII-XbaI fragment containing the amino-terminal part of CDC9 was cloned from pR12ScLig2 into the BamHI-XbaI sites of the vector pHSS6. This plasmid (pHSS6-CDC9) was subjected to transposon mutagenesis as described [23] . One haploid viable strain, MDY26, expressing a functional CDC9-HA was chosen for further analysis. Genomic DNA from MDY26 was amplified by PCR with primers L (5′-CACCTTAACGCGAAAACGCGTGAAAGTG-3′) and M (5′-TTTGACCCACAAAGGTGGGAAAAGTGCC-3′) and sequenced to determine the position of the 279 bp 3 × HA insertion. 
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